COMPANY NEWS

June 18, 2025

CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study

Frontiers in Veterinary Science paper reports rapid, significant pain relief with weekly p62-plasmid injections and no significant side-effects

November 14, 2024

November 14, 2024
CureLab Oncology Seeks to Revolutionize Chronic Pain Management with Novel p62-Based Therapy

Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for millions

October 16, 2024

October 16, 2024
CureLab CEO Dr. Alexander Shneider Unveils Promising Cancer Treatment at 2024 MedInvest Conference